106274-68-4

Basic information

• Product Name: 3-Amino-biphenyl-2-carbonitrile
• Synonyms: 3-amino-[1,1'-biphenyl]-2-carbonitrile
• CAS NO: 106274-68-4
• Molecular Formula: C₁₃H₁₀N₂
• Molecular Weight: 194
• Mol File: 106274-68-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Amino-biphenyl-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-biphenyl-2-carbonitrile(106274-68-4)
• EPA Substance Registry System: 3-Amino-biphenyl-2-carbonitrile(106274-68-4)

Safety Data

• Hazardous Substances Data: 106274-68-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Amino-biphenyl-2-carbonitrile is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of various medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Amino-biphenyl-2-carbonitrile is utilized as an intermediate, playing a role in the creation of substances that aid in agricultural processes.
Used in Dye Industry:
3-Amino-biphenyl-2-carbonitrile is employed as an intermediate in the production of dyes, where its chemical structure contributes to the color properties of the final products.
Used in Research and Development:
3-Amino-biphenyl-2-carbonitrile is used as a building block in research and development for the creation of various organic compounds, facilitating scientific investigations and studies.

Upstream product

• 99420-17-4 3-nitro-biphenyl-2-carbonitrile 
• 77326-62-6 2-amino-6-bromobenzonitrile 
• 98-80-6 phenylboronic acid 

Relevant articles and documents

A comparative study of the recent most potent small-molecule PD-L1 inhibitors: what can we learn?

Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have become a “game-changer” in the cancer treatment. However, none of the small molecular inhibitors has been approved yet. To explore the advantages and disadvantages of various scaffolds, di

Mn(III)-Mediated Cascade Cyclization of 3-Isocyano-[1,1′-biphenyl]-2-carbonitrile with Arylboronic Acid: Construction of Pyrrolopyridine Derivatives

A Mn(III) mediated cascade cyclization of new designed multifunctionalized 3-isocyano-[1,1′-biphenyl]-2-carbonitrile with arylboronic acid to construct pyrrolopyridine derivatives is developed. A series of pyrroloporidine compounds have been constructed through the formation of two new C-C bonds and one C-N bond via a radical pathway.

TBPB-initiated cascade cyclization of 3-arylethynyl-[1,1′-biphenyl]-2-carbonitriles with sulfinic acids: Access to sulfone-containing cyclopenta[: Gh] phenanthridines

A novel TBPB-initiated cascade cyclization of 3-arylethynyl-[1,1′-biphenyl]-2-carbonitriles with sulfinic acids via C-S, C-C and C-N bond formation for the synthesis of 3-sulfonated cyclopenta[gh]phenanthridines under metal-free conditions has been developed. This protocol features mild conditions, good functional group tolerance and a broad substrate scope. By using this protocol, a variety of potentially bioactive 3-sulfonated cyclopenta[gh]phenanthridines were facilely synthesized via direct annulation.

Triazolopyridine compound and preparation method and application thereof

The invention belongs to the technical field of medicine and relates to a triazolopyridine compound and a preparation method and application thereof, in particular to a triazolopyridine compound having the structure of general formula I and its stereoisomers and pharmaceutically acceptable salts, wherein R1, R2, R3 and R4 are described as in the claims and the description. All the triazolopyridinecompound, its stereoisomers and pharmaceutically acceptable salts, and a composition containing the triazolopyridine compound can evidently inhibit interaction of PD-1/PD-L1 protein/protein, are suitable for treating the various diseases, such as cancers and viral infections, and therefore, are applicable to the preparation of drugs to prevent and/or treat diseases associated with PD-1/PD-L1 signal pathway.

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Disclosed are compounds of Formula (I′), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

N-PHENYL-PYRIDINE-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS PD-1/PD-L1 PROTEIN/PROTEIN INTERACTION MODULATORS

Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.